enGene Reports Full Year 2025 Financial Results and Provides Business Update
enGene Holdings Inc. (Nasdaq: ENGN, enGene or the Company), a clinical-stage, non-viral genetic medicines company, today announced its financial results for the full year ended October 31, 2025, and...